|
Q1 FY2026
As of Feb 28, 2026
|
Q4 FY2025
As of Nov 30, 2025
|
Q3 FY2025
As of Aug 31, 2025
|
Q2 FY2025
As of May 31, 2025
|
Q1 FY2025
As of Feb 28, 2025
|
Q4 FY2024
As of Nov 30, 2024
|
Q3 FY2024
As of Aug 31, 2024
|
Q2 FY2024
As of May 31, 2024
|
Q1 FY2024
As of Feb 29, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Cash and cash equivalents | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Investments held in Trust Account | |||||||||
| Total assets | |||||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Deferred underwriting commissions | |||||||||
| Total liabilities | |||||||||
| Ordinary shares subject to possible redemption, $0.0001 par value; 200,000,000 shares authorized; 20,125,000 shares at redemption value at $10.98 and $10.87 per share as of February 28, 2026 and November 30, 2025, respectively | |||||||||
| Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 5,674,375 non- redeemable shares issued and outstanding (excluding 20,125,000 shares subject to possible redemption) issued and outstanding as of February 28, 2026 and November 30, 2025, respectively | |||||||||
| Accumulated deficit | |||||||||
| Total shareholders’ deficit | |||||||||
| Total Liabilities, Ordinary Shares Subject to Redemption and Shareholders’ Deficit |
Loading...
